Payoneer Global Inc. is a financial technology company that provides a multi-currency account for cross-border accounts receivable and accounts payable needs through its payment infrastructure platform. Its services include funds management, working capital, multi-currency accounts, and workforce management. The company also offers payment options requiring minimal integration, along with back-office functions and customer support. Founded in 2005, Payoneer Global Inc. is headquartered in New York, New York, and serves small and medium-sized businesses worldwide.
Payoneer opens India tech hub, plans to hire 300 engineers by end-2026
Nasdaq-listed fintech firm Payoneer Global plans to hire around 300 engineers by end of 2026 for its new global capability centre in India. The new facility in Gurugram near Delhi will become Payoneer's second-largest tech and R&D centre globally, focusing on AI and platform engineers. India site leader Gaurav Gupta said the key reason for coming to India is to tap into the talent density for building financial technologies at large scale with deep-tech expertise. The company already has a Bengaluru office with around 400 employees handling domestic sales. Gupta said the proposed acquisition of Payoneer by Canadian fintech Nuvei for about $2.75 billion would not impact the India GCC or local business operations.
Astrana Health Named Profitable Stock to Watch, AT&T and Payoneer Flagged as Sells
StockStory identifies Astrana Health as a profitable stock to target this week, while questioning AT&T and Payoneer. Astrana Health, formerly Apollo Medical Holdings, reported a 55.7% annual revenue growth over the last two years and a 13.2% annual increase in earnings per share over five years, with a forward P/E of 15.3. AT&T faces annual revenue declines of 1.3% over five years and a 7.5% annual drop in earnings per share, trading at 9 times forward P/E. Payoneer's earnings per share growth of 4.8% underperformed its revenue, and its return on equity stands at 7.3%, with shares at 25 times forward P/E.
ASTH · Capital · Positive StockStory highlights Astrana Health's strong revenue and earnings growth and low forward P/E as a profitable stock to watch.
PAYO · Capital · Negative StockStory flags Payoneer as a sell due to weak earnings growth relative to revenue and low return on equity.
T · Capital · Negative StockStory flags AT&T as a sell due to declining revenue and earnings per share over five years.
Payoneer’s Recent Rally Masks Weak EPS Growth and Low ROE, Analysts Say
Payoneer’s stock has returned 29.9% over the past six months, outpacing the S&P 500 by 20.9% and reaching $7.02 per share, but analysts at StockStory urge caution. They highlight that Payoneer’s EPS grew at a compounded annual rate of only 4.8% over the last two years, well below its 11% annualized revenue growth, signaling declining per-share profitability. Additionally, the company’s average return on equity over the past five years stands at 7.3%, below the sector average of around 10%. With the stock trading at 25.2 times forward earnings, the analysts believe too much optimism is priced in and recommend looking elsewhere, pointing to an entrenched endpoint security platform as a better alternative.
Benchmark Downgrades Payoneer to Hold After Nuvei Buyout Deal
Benchmark downgraded Payoneer Global to Hold from Buy on June 18, following Nuvei's agreement to acquire the company for $7.40 per share in cash. The downgrade reflects limited remaining upside after the acquisition announcement, as the offer price effectively establishes a valuation ceiling pending completion of the transaction. Earlier, on June 16, Deutsche Bank raised its price target on Payoneer to $7.40 from $6 while maintaining a Buy rating, aligning its valuation with the proposed acquisition price and recognizing the deal as validation of Payoneer's business model and growth strategy.
Ademi LLP investigates Payoneer's $2.75 billion deal with Nuvei
Ademi LLP is investigating Payoneer Global Inc. for possible breaches of fiduciary duty in its recently announced transaction with Nuvei. Payoneer stockholders will receive $7.40 per share in cash, representing a total transaction equity value of approximately $2.75 billion. The investigation focuses on whether the Payoneer board of directors is fulfilling its fiduciary duties to all shareholders, particularly given that insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement imposes a significant penalty if Payoneer accepts a competing bid, which the firm says unreasonably limits competing transactions.
Paymentus leads diversified financial services Q1 with 30% revenue growth
Paymentus reported first-quarter revenues of $358.4 million, up 30.2% year on year and exceeding analyst estimates by 6.4%, making it the top performer among the ten diversified financial services stocks tracked. The company also posted record revenue, with contribution profit growth of 25.2% and adjusted EBITDA growth of 41.5%, and raised its full-year guidance. Despite the strong results, Paymentus shares fell 14.7% since the report, while peer Payoneer saw a 46.3% gain after its own beat. The broader group averaged a 5.6% share price decline, with Western Union and NerdWallet also down double digits.
StockStory Highlights Datadog and Blue Bird as Cash-Rich Buys, Flags Payoneer as a Sell
StockStory identifies two cash-heavy stocks with strong fundamentals to buy and one to avoid. Datadog holds a net cash position of $3.47 billion, representing 4.2% of its market cap, and is praised for 29.5% annual recurring revenue growth and a projected 24% revenue increase over the next 12 months. Blue Bird has a net cash position of $187.9 million, or 8.3% of its market cap, with 14.3% annual revenue growth over five years and a free cash flow margin that jumped by 21 percentage points. Payoneer, with a net cash position of $337.3 million equal to 14.9% of its market cap, is flagged as a sell due to earnings per share growth lagging revenue gains and a low 7.3% return on equity.
BLBD · Capital · Positive StockStory highlights Blue Bird's strong net cash position, revenue growth, and improved free cash flow margin as buy signals.
DDOG · Capital · Positive StockStory praises Datadog's net cash position, high ARR growth, and projected revenue increase, recommending it as a buy.
PAYO · Capital · Negative StockStory flags Payoneer as a sell due to weak EPS growth relative to revenue and low return on equity.
Halper Sadeh LLC, an investor rights law firm, is investigating whether XOMA Royalty Corporation, Payoneer Global Inc., Fox Corporation, and National Storage Affiliates Trust are obtaining fair deals for their shareholders. The firm is examining XOMA's sale to Ligand Pharmaceuticals for $39.00 per share, Payoneer's sale to Nuvei for $7.40 per share in cash, Fox's merger with Roku where Fox shareholders would own approximately 73% of the combined company, and National Storage's sale to Public Storage for 0.14 of a Public Storage share or partnership unit per National Storage share or unit. Halper Sadeh may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages affected investors to contact the firm at no cost to discuss their legal rights and options.
FOXA · Regulation · Neutral Investigation into Fox's merger with Roku for shareholder fairness; potential legal action may affect deal terms.
PAYO · Regulation · Neutral Investigation into Payoneer's sale to Nuvei for shareholder fairness; potential legal action may affect deal terms.
XOMA · Regulation · Neutral Investigation into XOMA's sale to Ligand Pharmaceuticals for shareholder fairness; potential legal action may affect deal terms.
USA